Avac Event

You Get What You Measure: Why Monitoring for PrEP Choice Helps Tell Our Story

The data we collect on a program determines its path and priorities. This webinar covered the current state of PrEP M&E and efforts to improve and simplify the data we collect, allowing our data to better reflect how people are using PrEP, support PrEP choice amongst the growing array of PrEP methods, and enhance the stories we can tell about PrEP program implementation.

Presenters:

  • Katharine Kripke, Avenir Health, MOSAIC
  • Jessica Williamson, Avenir Health, MOSAIC

Panelists:

  • Omolabake Ekundayo, Ministry of Health Nigeria
  • Dr. Herbert Kadama, Ministry of Health Uganda
  • Ramatsoai Soothoane, Jhpiego, MOSAIC Project Lesotho

Moderator:

  • Adaobi Olisa, FHI360, MOSAIC Project Nigeria

This webinar offered live French and Portuguese translation, courtesy of the South-to-South Learning Network in Africa.

Co-sponsors:

  • BioPIC
  • South-to-South Learning Network
  • The MOSAIC Project

Recording in English / French Audio Recording / Portuguese Audio Recording / Webinar Slides / Strengthening and Harmonising PrEP Indicators

Avac Event

Responding to Project 2025’s Threats to Science, Rights and Resources

Project 2025 is part of an ongoing multi-pronged backlash to the sexual and reproductive health, gender and LGBTQ+ movements. This has serious implications for both domestic and foreign policies and programs for our communities and beyond. Building on the experience of the HIV movement in fighting these same far-right forces, this webinar discussed potential responses through the lens of HIV affected communities and programs.

Speakers:

  • Sean Cahill, The Fenway Institute
  • Aleksei Lakhov, EuroNPUD
  • Will Ramirez, Southern AIDS Coalition
  • Beirne Roose-Snyder, Council for Global Equality
  • Olabukunola (Buky) Williams, AKINA MAMA WA AFRIKA

Moderators:

  • Anne-christine d’Adesky, Stop the Coup 2025
  • Allan Maleche, KELIN

Co-sponsors:

  • AVAC
  • European AIDS Treatment Group
  • EuroNPUD
  • The Fenway Institute
  • Funders Concerned About AIDS
  • GSSG Foundation
  • KELIN
  • Southern AIDS Coalition
  • Stop the Coup 2025

Recording / Slides / Resources / Chat

Avac Event

The GPP Body of Evidence: GPP Monitoring and Evaluation Frameworks, REAL and REAL2

GPP is an essential part of clinical trials research, and an ethical imperative to creating equitable and effective clinical trials. GPP is created by and for communities, so it necessarily looks different and takes multiple forms in different cultural contexts. This kind of responsiveness is inherent to GPP, but it also makes it difficult to measure and evaluate.

In this webinar, we learned from the Realist Review of Community Engagement and the REAL2 review of participatory research that both examined frameworks for evaluating community engagement efforts, as well as the Global Health Network’s new course on evaluation, and other evaluation efforts in the field of GPP.

Moderator:

  • Jessica Salzwedel, AVAC

Panelists:

  • Alun Davies, The Global Health Network
  • Sassy Molyneux, KEMRI-Wellcome Trust
  • Dr. Robin Vincent, Oxford University

Recording / Alun Davies Slides / Sassy Molyneux Slides / Dr. Robin Vincent Slides

Avac Event

It’s Not Just about the Trial: GPP from discovery to delivery in TB research

GPP enhances every stage of the research lifecycle. In this webinar, our partners at TB Alliance, SMART4TB, and THINK will shared experiences, lessons learned, and innovative approaches in integrating GPP at the organizational, network and situational level, from drug development through delivery.

Moderators:

  • Stacey Hannah, AVAC
  • Dr. Michele Tameris, University of Cape Town

Panelists:

  • Stephanie Seidel, TB Alliance
  • Erica Lessem, SMART4TB
  • Masingita Lambane, THINK

Recording / Stephanie Seidel Slides / Erica Lessem Slides / Masingita Lambane Slides

Avac Event

Using the COMPASS Campaign Advocacy Assessment Tool (C-CAAT) to assess the effectiveness of advocacy campaigns

This webinar is for all COMPASS coalition members, partners, stakeholders and individuals taking on advocacy in various fields.

By the end of the webinar participants are expected to have an improved capacity on how to reflect on advocacy outcomes (positive and negative) individually and collectively with relevant stakeholders and partners; enhanced ability to identify, describe and document advocacy outcomes in a clear and structured manner; and an improved capacity to identify follow up actions/tactics needed to achieve the advocacy goal or respond in the event of a setback.

Avac Event

From the Lab to the Jab: Lessons learned and what’s next in HIV vaccine research

AVAC’s issue briefs, From the Lab to the Jab, cover the barriers to, and solutions for equitable access to vaccines in low- and middle-income countries. During this webinar, an expert panel discussed lessons learned, an international initiative for vaccine development, and how research and access can be improved.

Moderators:

  • Mitchell Warren, AVAC
  • Tracy Swan, AVAC and Make Medicines Affordable Campaign

Panelists:

  • Dr. Jerome Kim, International Vaccine Institute
  • Dr. Els Torreele, æqua
  • Othoman Mellouk, International Treatment Preparedness Coalition

Recording / Dr. Jerome Kim Slides / Dr. Els Torreele Slides / Othoman Mellouk Slides

Avac Event

HIV, Viral Hepatitis and Sexually Transmitted Infections: Progress and gaps

13:00 – 14:30 CEST PM

Please join this webinar being held in the run up to the 77th World Health Assembly.

The World Health Organization (WHO) will launch a publication, which describes progress and gaps identified during the first two years of implementing the global health sector strategies on HIV, viral hepatitis and sexually transmitted infections (STIs) for 2022-2030.

Moderators will ask key leaders in the responses to HIV, viral hepatitis and STIs how we can increase visibility, political will and community activism to accelerate action.

Panelists include:

  • Jérôme Salomon, WHO, Switzerland
  • Jessica Hicks, World Hepatitis Alliance, United Kingdom
  • Maureen Luba, AVAC, Malawi
  • Meg Doherty, WHO, Switzerland
  • Patty Garcia, Cayetano Heredia University, Peru
  • Philippe Duneton, Unitaid, Switzerland
  • Sabin Nsanzimana, Ministry of Health, Rwanda (TBC)

The conversation will be moderated by Charles Gore from the Medicines Patent Pool (MPP) and Birgit Poniatowski from IAS – the International AIDS Society.

The webinar is organized by IAS – the International AIDS Society – and its partners, WHO, Medicines Patent Pool and Unitaid.

Avac Event

Analysis & Impact of the Ugandan Constitutional Court Ruling on HIV Services

Please join us for a deep dive into the recent ruling on the Anti-Homosexuality Act by the Ugandan Constitutional Court, with a focus on implications for HIV programs in Uganda and beyond, and connections to the US Supreme Court Dodds decision.

Speakers Include:

  • Andrea Gillespie, Associate Director of Global Advocacy, Human Rights Campaign
  • Maureen Milanga, Director International Policy and Advocacy, Health GAP
  • Ugandan activist TBC

Avac Event

PrEP and the Role of HIV Self-Testing

HIV self-testing (HIVST) is a safe, accurate, and effective alternative to provider-administered testing that many users prefer for its convenience and confidentiality. At IAS 2023, WHO issued a new recommendation to offer HIVST for PrEP initiation and continuation as an innovative way to increase PrEP access and coverage and further simplify PrEP delivery. However, many implementers still have questions on how to effectively roll out and scale up this important self-care intervention.

On May 23, AVAC and WHO hosted a webinar to learn more about WHO guidance on use of HIVST and to hear directly from a panel of experts on their experiencing rolling out HIVST for PrEP, guidance on procurement and costing, and more.

Recording / Slides

Avac Event

The Importance of HPV Vaccination Among People Living with HIV

HPV vaccination prevents 6 types of cancer and genital warts, including cervical cancer. Women living with HIV are up to six times more likely to develop invasive cervical cancer than their HIV-negative peers, but HPV immunization rates among this population remain low. During World Immunization Week, AVAC and TogetHER for Health co-hosted a discussion to learn more about the science behind and implementation challenges specific to expanding access to HPV vaccination for people living with HIV.

  • Mandisa Dukashe, HIV Survivors and Partners Network
  • Dr. Betty Njoroge, Kenya Medical Research Institute
  • Dr. Christopher Morgan, Jhpiego

This webinar was co-hosted with TogetHER for Health

Recording / Mandisa Dukashe Slides / Dr. Betty Njoroge Slides / Dr. Christopher Morgan Slides